Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassani, Erica, Cancello, Raffaella, Cavanna, Ferruccio, Maestrini, Sabrina, Di Blasio, Anna Maria, Liuzzi, Antonio, Pezzoli, Gianni, Barichella, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135047/
https://www.ncbi.nlm.nih.gov/pubmed/21766000
http://dx.doi.org/10.4061/2011/624764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135047/
https://www.ncbi.nlm.nih.gov/pubmed/21766000
http://dx.doi.org/10.4061/2011/624764

Ejemplares similares